Page last updated: 2024-08-22
1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Hodgkin Disease
1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Hodgkin Disease in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Allen, J; Hancock, C; Tan, CT | 1 |
Other Studies
1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Hodgkin Disease
| Article | Year |
|---|---|
Phase II trial of PCNU in children with recurrent brain tumors and Hodgkin's disease.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Hodgkin Disease; Humans; Infant; Infusions, Parenteral; Male; Neoplasm Recurrence, Local; Neoplasms, Nerve Tissue; Nitrosourea Compounds | 1984 |